Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

1032 Results

View

Closed

Phase

Accrual

56%

Published

SWOG Clinical Trial Number

S0031

Evaluation of ZD 1839 (NSC #715055) for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II

Research Committee(s)

Genitourinary Cancer

Activated

02-15-2001

Closed

10-15-2002

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S9915

A Phase II Study of PN401, 5-FU, and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach.

Research Committee(s)

Gastrointestinal Cancer

Activated

02-15-2001

Closed

09-01-2002

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S0033

"Phase III Randomized, Intergroup Trial Assessing the Clinical Activity of STI-571 at Two Dose Levels in Patients with Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST) Expressing the KIT Receptor Tyrosine Kinase (CD117)"

Research Committee(s)

Sarcoma

Activated

12-15-2000

Closed

09-01-2001

Closed

Phase

Accrual

72%

Published

SWOG Clinical Trial Number

S0003

Randomized Phase III Trial of Carboplatin and Paclitaxel plus Tirapazamine versus Carboplatin and Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer - Cisplatin, Paclitaxel, Tirapazamine vs. Cisplatin, Paclitaxel - Specimen submission per S9925

Research Committee(s)

Lung Cancer

Activated

11-15-2000

Closed

11-15-2002

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S0007

Evaluation of 3 Hour Infusion of Paclitaxel Plus Cisplatin and 5-Fluorouracil in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Research Committee(s)

Head and Neck Cancer

Activated

11-01-2000

Closed

05-15-2003

Closed

Phase

Accrual

Published

SWOG Clinical Trial Number

S0019

A Randomized Phase III Trial of ICE Chemotherapy With or Without Rituximab for the Treatment of Relapsed or Refractory CD20 Expressing Agressive B-Cell Non-Hodgkin's Lymphomas in Patients Not Suitable for High Dose Therapy and PBSCT.

Research Committee(s)

Lymphoma

Activated

10-15-2000

Closed

12-15-2001

Closed

Phase

Accrual

60%

Published

SWOG Clinical Trial Number

S0004

A Phase I Study of Tirapazamine/Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer

Research Committee(s)

Lung Cancer

Activated

10-15-2000

Closed

04-01-2002

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S9912

Phase II Evaluation of Intravenous Paclitaxel, Intraperitoneal Cisplatin, Intravenous Liposomal Doxorubicin and Intraperitoneal Paclitaxel in Women with Optimally-Debulked Stage III Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Research Committee(s)

Gynecologic Cancer

Activated

10-01-2000

Closed

08-15-2005

Closed

Phase

Accrual

36%

Published

SWOG Clinical Trial Number

S0013

Evaluation of In Vitro Assays as Predictors of Clinical Outcome in Patients With Locally Advanced (Stage IIB-IVA)Cervical Carcinoma, Biologic

Research Committee(s)

Gynecologic Cancer

Activated

09-15-2000

Closed

11-15-2003

Closed

Phase

SWOG Clinical Trial Number

S9925

Lung Cancer Specimen Repository Protocol, Ancillary

Research Committee(s)

Lung Cancer

Activated

09-01-2000

Closed

03-15-2010

Closed

Phase

Accrual

90%

Published

SWOG Clinical Trial Number

S0008

Phase III Trial of High Dose Interferon Alpha-2b versus Cisplatin, Vinblastine, DTIC Plus IL-2 and Interferon in Patients with High Risk Melanoma

Research Committee(s)

Melanoma

Activated

08-01-2000

Closed

11-15-2007

Closed

Phase

Accrual

48%

SWOG Clinical Trial Number

S0010

A Phase II Trial of 506U78 (IND 52611) in Patients With Relapsed or Refractory Non T-Cell Acute Lymphoblastic Leukemia (ALL)

Research Committee(s)

Leukemia

Activated

07-15-2000

Closed

03-15-2004

Closed

Phase

Accrual

SWOG Clinical Trial Number

S9920

A Phase III Randomized Study Comparing Busulfan – Total Body Irradiation Versus Cyclophosphamide – Total Body Irradiation Preparative Regimen in Patients with Advanced Myelodysplastic Syndrome (MDS) or MDS – Related Acute Myeloid Leukemia (AML) Undergoing HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation, (A BMT Study)

Research Committee(s)

Leukemia

Activated

06-15-2000

Closed

10-15-2001

Closed

Phase

Accrual

SWOG Clinical Trial Number

S9927

Randomized Trial of Post-Mastectomy Radiotherapy in Stage II Breast Cancer in Women With One to Three Positive Axillary Nodes, Phase III

Research Committee(s)

Breast Cancer

Activated

06-15-2000

Closed

06-15-2003

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S9923

A Phase II Trial of R115777 (NSC #70818) in Patients with Advanced Colorectal Cancer.

Research Committee(s)

Gastrointestinal Cancer

Activated

06-01-2000

Closed

08-01-2001

Closed

Phase

Accrual

97%

Published

SWOG Clinical Trial Number

S9924

A Phase II Trial of R115777 (NSC #70818) in Patients with Advanced Pancreas Cancer.

Research Committee(s)

Gastrointestinal Cancer

Activated

06-01-2000

Closed

06-01-2001

Closed

Phase

Accrual

SWOG Clinical Trial Number

S9901

A Randomized Phase III Trial Comparing Early High Dose Chemotherapy and an Autologous Stem Cell Transplant to Conventional Dose ABVD Chemotherapy for Patients with Advanced Stage Poor Prognosis Hodgkin’s Disease as Defined by the International Prognostic Factors Project on Advanced Hodgkin’s Disease, Intergroup

Research Committee(s)

Lymphoma

Activated

04-15-2000

Closed

11-01-2001

Closed

Phase

Accrual

SWOG Clinical Trial Number

S9922

A Phase III Trial of Dexamethasone, Cyclophosphamide, Etoposide, Cisplatin (DCEP) and G-CSF With or Without Thalidomide (NSC #66847) as Salvage Therapy for Patients with Refractory Multiple Myeloma

Research Committee(s)

Myeloma

Activated

04-15-2000

Closed

11-01-2001

Closed

Phase

Accrual

56%

SWOG Clinical Trial Number

S9926

Phase II Study of Temozolomide in Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST)

Research Committee(s)

Sarcoma

Activated

04-15-2000

Closed

09-01-2003

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S0014

Evaluation of CHOP Plus Rituximab Plus Involved Field Radiotherapy for Stages I, IE, and Non-Bulky Stages II and IIE, CD20 Positive, High Risk Localized Aggressive Histologies of Non-Hodgkin’s Lymphoma, Phase II

Research Committee(s)

Lymphoma

Activated

04-01-2000

Closed

01-15-2002